A manufacturing ramp should be assessed through its cost absorption and reporting perimeter, not sales growth alone.
One growth rate, two different businesses
Aequs’ latest results are easier to understand as a comparison of two manufacturing businesses than as a single growth headline. The company’s aerospace operations and its consumer operations are moving through different economic stages. Adding their sales together is necessary for a consolidated result, but it does not explain how the result was produced.
In its October 26 release for the quarter ended September 30, Aequs reports consolidated revenue of ₹409.1 crore, up 45% year on year. EBITDA is ₹24.5 crore, down 45%, and the reported loss after tax is ₹52.2 crore. These are conversions from the company’s million-rupee presentation. The profit figure is negative; this is not a profitable quarter at the consolidated level.
The release gives the contrast inside the total. Aerospace quarterly revenue is ₹351.4 crore, with EBITDA of ₹78.3 crore. Consumer revenue is ₹57.7 crore, while that business reports an EBITDA loss of ₹40.1 crore. Those disclosed segment measures are useful, but should not be mechanically added to reconstruct group EBITDA without considering the reporting reconciliation.
The first page of the results release also warns that the current quarter and half-year figures are not directly comparable with their prior-year periods because consumer-electronics costs are now being expensed rather than remaining in the pre-operative phase. That warning belongs next to the growth rates. It is part of the result, not a footnote to discard after reading the headline.
A ramp consumes capacity before it proves economics
A manufacturing expansion can produce more sales while still absorbing costs poorly. In a hypothetical new operation, equipment, staff and supporting processes may be in place before output reaches a level that makes efficient use of them. More revenue would then be a sign of activity, but not sufficient evidence that the operation has reached a sustainable margin.
Aequs’ segment discussion describes the consumer ramp as affecting cost absorption. The analytical issue is how that phase progresses, not whether the words “growth” and “loss” can coexist. They plainly can. The useful question is what additional operating evidence would show that higher volume is improving the relationship between cost and output.
That evidence might include production yields, utilisation, product mix and the cost of serving customers. These are examples of measures an analyst could seek, not numbers supplied in this article or claims about Aequs’ specific performance. It would be wrong to invent a break-even date from one quarter’s sales and losses.
The contrast with aerospace is useful without becoming a promise that one business will always subsidise the other. A stronger current segment result and a weaker ramp-stage result can sit inside the same group. Whether that combination is attractive depends on future evidence about capital needs and earnings quality, which the headline growth figure does not settle.
Keep the Q2 reporting layers separate
Consolidated
Revenue ₹409.1 crore; EBITDA ₹24.5 crore; PAT loss ₹52.2 crore.
Aerospace segment
Revenue ₹351.4 crore and EBITDA ₹78.3 crore.
Consumer segment
Revenue ₹57.7 crore and EBITDA loss ₹40.1 crore; segment figures are not a full group reconciliation.
Comparison warning
The release flags changed treatment of consumer-electronics costs; JV-inclusive figures use another perimeter.
Keep the accounting perimeter consistent
The release also presents a measure including proportionate joint-venture contributions. That is not the same perimeter as the consolidated figures used at the start of this article. A reader should not take revenue from one presentation and EBITDA from another to construct a margin. The apparent precision of the arithmetic would hide a mismatch in the underlying measure.
This matters beyond a listed manufacturer. A deeptech startup can also report several versions of commercial progress: orders, shipments, recognised revenue, partner output or revenue including a joint venture. Each can be useful when clearly defined. Comparing them as if they were interchangeable can create a misleading account of scale.
For founders, the case offers a practical way to write a more credible operating update. State what has grown, identify the costs attached to that growth and disclose any change in comparability. A funding or sales narrative becomes stronger when it leaves room for the difficult phase of implementation, rather than pretending that every additional order has the same economics.
The segment discussion gives readers a starting explanation of this particular quarter. It does not provide independent evidence that the consumer ramp will achieve management’s future aims. Foundra has not inspected Aequs’ factories, interviewed its customers or validated production performance.
The next milestone is not another adjective
A subsequent update would be more informative if it showed how the consumer cost-absorption issue changes while keeping the reporting basis clear. That is an evaluation question, not a forecast that the loss will narrow. Aerospace profitability, consumer investment and group cash needs should remain separate parts of the assessment.
Aequs’ announcement demonstrates why industrial growth is not a single-speed story. The sales increase is real as reported, and the consolidated loss is real as reported. Reading them together—with the comparability warning and the distinct segment economics—produces a more useful picture than choosing whichever number best supports an optimistic or pessimistic headline.
Sources
- Aequs — October 26 Q2 FY2027 company results release ↗ Aequs — October 26 Q2 FY2027 company results release · Primary source
Have additional information? Request a correction.



